1. Accueil
2. FDA grants orphan-drug designation to ZENEO® Midazolam

FDA grants orphan-drug designation to ZENEO® Midazolam

Image

Date de parution

01/02/2018

Sommaire ou résumé

The FDA has granted ZENEO® Midazolam orphan-drug designation for "treatment of status epilepticus".

 

PDF du document

2018_02_01 Crossject- FDA grants orphan-drug designation to ZENEO Midazolam.pdf480.7 Ko